ZA915932B - (2r)-2-(di(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use - Google Patents

(2r)-2-(di(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use

Info

Publication number
ZA915932B
ZA915932B ZA915932A ZA915932A ZA915932B ZA 915932 B ZA915932 B ZA 915932B ZA 915932 A ZA915932 A ZA 915932A ZA 915932 A ZA915932 A ZA 915932A ZA 915932 B ZA915932 B ZA 915932B
Authority
ZA
South Africa
Prior art keywords
trimethylacetoxypropane
phosphonylmethoxy
toluenesulfonyloxy
propyl
preparation
Prior art date
Application number
ZA915932A
Other languages
English (en)
Inventor
Petr Alexander
Alexander Petr
Antonin Holy
Holy Antonin
Hanna Dvorakova
Dvorakova Hanna
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Publication of ZA915932B publication Critical patent/ZA915932B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA915932A 1990-08-06 1991-07-29 (2r)-2-(di(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use ZA915932B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS903871A CS276072B6 (en) 1990-08-06 1990-08-06 (2R)-2-/DI(2-PROPYL)PHOSPHONYLMETHOXY/-3-p-TOLUENESULFONYLOXY -1- TRIMETHYLACETOXYPROPANE AND PROCESS FOR PREPARING THEREOF

Publications (1)

Publication Number Publication Date
ZA915932B true ZA915932B (en) 1992-04-29

Family

ID=5380072

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915932A ZA915932B (en) 1990-08-06 1991-07-29 (2r)-2-(di(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use

Country Status (13)

Country Link
US (2) US5130427A (xx)
EP (1) EP0470809A1 (xx)
JP (1) JP2955402B2 (xx)
AU (1) AU8149291A (xx)
CA (1) CA2046755C (xx)
CS (1) CS276072B6 (xx)
FI (1) FI913702A (xx)
IE (1) IE71217B1 (xx)
IL (1) IL98849A0 (xx)
NO (1) NO913035L (xx)
NZ (1) NZ239131A (xx)
PT (1) PT98590B (xx)
ZA (1) ZA915932B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284678B6 (cs) * 1991-05-20 1999-01-13 Ústav Organické Chemie A Biochemie Avčr Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
JP2532818B2 (ja) 1993-02-01 1996-09-11 松下電器産業株式会社 対物レンズおよび光ヘッド装置
US5502177A (en) * 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
JP4555536B2 (ja) * 2000-02-18 2010-10-06 サザン・リサーチ・インスティテュート ２−クロロ−９−（２−デオキシ−２−フルオロ−β−Ｄ−アラビノフラノシル）−９Ｈ−プリン−６−アミンの合成方法
DK2682397T3 (da) 2000-07-21 2017-06-19 Gilead Sciences Inc Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
AU2003299492B2 (en) * 2002-05-13 2010-06-10 Metabasis Therapeutics, Inc. Cyclic prodrugs of PMEA one of its analogues
EP1504014B1 (en) * 2002-05-13 2015-12-02 Metabasis Therapeutics, Inc. Process for preparation of cyclic prodrugs of pmea and pmpa
KR20070029196A (ko) * 2004-06-08 2007-03-13 메타베이시스 테라퓨틱스, 인크. 고리 에스테르의 루이스 산 매개 합성
US9622967B2 (en) 2010-12-10 2017-04-18 Sigmapharm Laboratories, Llc Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
EP3578563B1 (en) 2011-12-22 2021-04-14 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
EP3105238A4 (en) 2014-02-13 2017-11-08 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
EP3164136A4 (en) 2014-07-02 2018-04-04 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
CN111788196A (zh) 2018-01-09 2020-10-16 配体药物公司 缩醛化合物及其治疗用途
JP7151348B2 (ja) * 2018-10-03 2022-10-12 日本製鉄株式会社 金属板用塗料およびこれを用いた塗装金属板の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868187A (en) * 1980-09-16 1989-09-19 Syntex (U.S.A.) Inc. Anti-viral N-substituted pyrimidines
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
AU8092587A (en) * 1986-11-18 1988-05-19 Bristol-Myers Squibb Company Synthesis of purin-9-ylalkylenoxymethyl phosphonic acids
US4927830A (en) * 1988-04-08 1990-05-22 The Regents Of The University Of Michigan Acyclic pyrrolo[2,3-D]pyrimidine analogs as antiviral agents
US4968686A (en) * 1988-04-08 1990-11-06 The Regents Of The University Of Michigan Acyclic pyrrolo [2,3-d]pyrimidine analogs as antiviral agents
WO1992002511A1 (en) * 1990-08-10 1992-02-20 Bristol-Myers Squibb Company Novel process for the preparation of nucleotides

Also Published As

Publication number Publication date
PT98590A (pt) 1992-06-30
CA2046755C (en) 2002-02-12
NO913035L (no) 1992-02-07
USRE35558E (en) 1997-07-08
FI913702A0 (fi) 1991-08-02
EP0470809A1 (en) 1992-02-12
PT98590B (pt) 1999-04-30
CS387190A3 (en) 1992-03-18
IL98849A0 (en) 1992-07-15
CA2046755A1 (en) 1992-02-07
US5130427A (en) 1992-07-14
CS276072B6 (en) 1992-03-18
FI913702A (fi) 1992-02-07
JPH05230087A (ja) 1993-09-07
AU8149291A (en) 1992-02-13
NO913035D0 (no) 1991-08-05
IE71217B1 (en) 1997-02-12
IE912758A1 (en) 1992-02-12
NZ239131A (en) 1994-04-27
JP2955402B2 (ja) 1999-10-04

Similar Documents

Publication Publication Date Title
PH30928A (en) Pharmaceutical agents.
HUP9801570A3 (en) Polysiloxane-comprising perfluoroalkyl ethers, and the preparation and use thereof
IE900184L (en) Grisle wire for medical use.
EP0685202A3 (en) Fabric measures.
ZA915932B (en) (2r)-2-(di(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use
ZA951374B (en) Ranitidine solid dosage form
OA09308A (en) Anti-HIV agent.
EP0472078A3 (en) Phosphonopyrrolidin- and piperidin-containing statin-type pseudopeptides, their preparation and use against retroviruses
GB9001886D0 (en) Pharmaceutical formulation
PL286620A1 (en) Microbiocidal agent
EP0536311A4 (en) Compositions comprising vitamin d precursors, analogs thereof and their use
ZA944187B (en) Ipsapirone medicament formulation
GB9000241D0 (en) Pharmaceutical use
GB9418550D0 (en) Drug formulation
ZA917789B (en) Pharmaceutical preparation.
ZA957349B (en) Pharmaceutical formulations.
CA63211S (en) Medicament applicator
GB8900228D0 (en) Pharmaceutical use
GB9023646D0 (en) New pharmaceutical use
GB9004372D0 (en) New pharmaceutical use
GB9023637D0 (en) New pharmaceutical use
GB9023656D0 (en) New pharmaceutical use
GB9014231D0 (en) New pharmaceutical use
GB9014230D0 (en) New pharmaceutical use
GB9004360D0 (en) New pharmaceutical use